Peptide Therapeutics intermediate
Milestone 030: Oligopeptide Research Reference
2010: First peptide-drug conjugate (brentuximab vedotin) approved. This peptide or oligopeptide is studied for its biological activity, structure-activity re...
By Encyclopeptide Editorial | 1 min read
milestone-030 peptide research
Overview
2010: First peptide-drug conjugate (brentuximab vedotin) approved.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Milestone 030” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Milestone 030: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept